ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Friday, 13 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Manipal Health Enterprises Investor Presentation: Key Takeaways

Q2 FY27 revenue ₹3,399 Cr (+37.3%), EBITDA ₹882 Cr (+29.8%), margin 26.0%, PAT ex-exceptions ₹380 Cr (+21.6%). Growth is volume-led, helped by Sahyadri consolidation.

Manipal Health Enterprises Q2 FY27 concall: date, live audio and summaryConcall page →
Highlights
Revenue growth+37.3% YoY, Sahyadri-inclusive
MarginsEBITDA margin 26.0%, down 150bps YoY; up 180bps QoQ
Demand visibilityOccupancy 70.1%, up 160bps; IP volumes accelerating
Management confidencePositive; cites sustained patient demand

Growth

Revenue +37.3% YoY, H1 +37.7%. IP volumes +35.0%. ARPOB ex-Sahyadri +8.5%.

Outlook

No explicit numerical guidance. Electronic City 300-bed hospital opened; Sahyadri rebrand targeted Q4 FY27.

Risks

EBITDA margin down 150bps YoY to 26.0%. Finance costs rose to ₹300 Cr. Exceptional charges of ₹95 Cr in Q2.

Last quarter's promises, checked

Delivered

  • Guided 300-bed Electronic City hospital opening in Q2 FY27 → opened in Q2 as guided (= BEAT)
  • Guided net debt/EBITDA 0.9x after Q2 debt repayment → 0.10x, net debt ₹343 Cr (= BEAT)
Source

Investor Presentation filed with NSE, NSE: MANIPALHOS. Summary written with AI assistance from the document.

Read the document ↗

Manipal Health Enterprises Ltd: key numbers

Share price
₹677.05
Market cap
₹89,058 Cr
Revenue (annual)
₹10,336 Cr
Net profit (annual)
₹892.3 Cr
Promoter holding
72.08%
FII holding
3.51%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Manipal Health Enterprises Ltd

All →